Status:
COMPLETED
Radiofrequency of Breast Cancers in Non Surgical Patients
Lead Sponsor:
Institut Bergonié
Conditions:
Breast Cancer
Eligibility:
FEMALE
70+ years
Phase:
NA
Brief Summary
To determine the efficacy and tolerance of ultrasonography (US)-guided percutaneous radiofrequency (RF) ablation with endocrine therapy in elderly patients with breast cancer who decline or are not ca...
Detailed Description
There is increasing demand for minimally invasive treatments for small breast malignancies. This is due in part to increased availability of improved treatment approaches, with the introduction of neo...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients more than 70 years old
- Breast tumors with estrogen receptors
- Non surgical patients
- Life expectancy more than 6 months
- Exclusion criteria:
- Presence of a pace maker
- Tumors measuring more than 30 mm on ultrasound evaluation, located less than 10 mm from skin, nipple, or pectoral muscle
- Coagulation disorders
- Contra indications to magnetic resonance imaging or computed tomography with contrast medium injection
- Non visible lesions on magnetic resonance imaging or computed tomography with contrast medium injection
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00210223
Start Date
January 1 2004
End Date
December 1 2011
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
Bordeaux, France, 33076